Balter Invenomic Fund Quote

BIVIX Fund  USD 17.56  0.05  0.29%   

Performance

Soft

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Balter Invenomic is trading at 17.56 as of the 16th of February 2026; that is 0.29 percent up since the beginning of the trading day. The fund's open price was 17.51. Balter Invenomic has about a 21 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 18th of November 2025 and ending today, the 16th of February 2026. Click here to learn more.
The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Under normal market conditions, the Sub-Adviser seeks to be fully invested in the long portfolio , while allowing the size of the short portfolio to fluctuate based on the market opportunity. More on Balter Invenomic Fund

Moving together with Balter Mutual Fund

  1.0BIVRX Balter InvenomicPairCorr
  0.63QLEIX Aqr Long ShortPairCorr

Moving against Balter Mutual Fund

  0.57NLSCX Neuberger Berman LongPairCorr
  0.56NLSAX Neuberger Berman LongPairCorr
  0.55NLSIX Neuberger Berman LongPairCorr
  0.36CISGX Touchstone Sands CapitalPairCorr

Balter Mutual Fund Highlights

Fund ConcentrationInvenomic Funds, Large Funds, Long-Short Equity Funds, Long-Short Equity, Invenomic (View all Sectors)
Update Date31st of December 2025
Expense Ratio Date1st of March 2025
Fiscal Year EndOctober
Balter Invenomic Fund [BIVIX] is traded in USA and was established 16th of February 2026. Balter Invenomic is listed under Invenomic category by Fama And French industry classification. The fund is listed under Long-Short Equity category and is part of Invenomic family. This fund currently has accumulated 988.42 M in assets under management (AUM) with no minimum investment requirementsBalter Invenomic is currently producing year-to-date (YTD) return of 1.21% with the current yeild of 0.02%, while the total return for the last 3 years was 0.35%.
Check Balter Invenomic Probability Of Bankruptcy

Instrument Allocation

Sector Allocation

Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Balter Mutual Fund. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Balter Mutual Fund, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Balter Invenomic Fund Mutual Fund, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.

Balter Invenomic Risk Profiles

Balter Invenomic Against Markets

Balter Mutual Fund Analysis Notes

The fund generated five year return of 21.0%. Balter Invenomic holds about 70.47% of assets under management (AUM) in cash. This fund last dividend was 0.01 per share. Large For more info on Balter Invenomic Fund please contact the company at 844-322-8112.

Balter Invenomic Investment Alerts

The fund holds about 70.47% of its assets under management (AUM) in cash

Top Balter Invenomic Fund Mutual Fund Constituents

Institutional Mutual Fund Holders for Balter Invenomic

Have you ever been surprised when a price of an equity instrument such as Balter Invenomic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Balter Invenomic Fund backward and forwards among themselves. Balter Invenomic's institutional investor refers to the entity that pools money to purchase Balter Invenomic's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Note, although Balter Invenomic's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Balter Invenomic Outstanding Bonds

Balter Invenomic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Balter Invenomic uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Balter bonds can be classified according to their maturity, which is the date when Balter Invenomic Fund has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Balter Invenomic Predictive Daily Indicators

Balter Invenomic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Balter Invenomic mutual fund daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Balter Invenomic Forecast Models

Balter Invenomic's time-series forecasting models are one of many Balter Invenomic's mutual fund analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Balter Invenomic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Other Information on Investing in Balter Mutual Fund

Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios